Pretreatment plasminogen activator inhibitor-1 (PAI-1) levels and the outcome of thrombolysis with streptokinase in patients with acute myocardial infarction

American Heart Journal

Volumn 136, Issue 3, 1998, Pages 406-411

  Sinkovic, A ^a  

^a UNIVERSITY MEDICAL CENTRE MARIBOR   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ALLERGIC REACTION; ARTICLE; BLOOD CLOT LYSIS; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE REPERFUSION; HEART REINFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROGNOSIS; TREATMENT FAILURE;

EID: 0031660254     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(98)70213-3     Document Type: Article

References (31)

1. V Fuster L Badimon M Cohen Insights into the pathogenesis of acute ischemic syndromes N Engl J Med 77 1988 1213 1220
2. TC. Smitherman Considerations affecting selection of thrombolytic agents Mol Biol Med 8 1991 207 218
3. Fibrinolytic Therapy Trialists’ FTT Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet 343 1994 311 322
4. CB Granger RM Califf EJ. Topol Thrombolytic therapy for acute myocardial infarction. A review Drugs 44 1992 293 325
5. B Cercek M Horvat A Brucan Brief, high-dose intravenous streptokinase infusion during the first three hours of acute myocardial infarction Zdravstveni Vestnik 52 1983 389 392
6. M Sesto Z Batinic V Goldner Systemic and selective application of streptokinase in acute myocardial infarction Lijec Vjesn 108 1986 77 83
7. Z Durakovic A Smalcelj R Radonic Ocjena djelotvornosti streptokinaze u akutnom infarktu miokarda s obzirom na pumpnu funkciju srca Acta medica Iugoslavica 44 1990 185 196
8. BS. Coller Platelets and thrombolytic therapy N Engl J Med 322 1990 33 42
9. WJ Marder S. Sherry Thrombolytic therapy: current status N Engl J Med 318 1988 1512 1520
10. S Fujii DR Abendschein BE. Sobel Augmentation of plasminogen activator inhibitor type 1 activity in plasma by thrombosis and by thrombolysis J Am Coll Cardiol 18 1991 1547 1557
11. S Fujii WE Hopkins BE. Sobel Mechanisms contributing to increased synthesis of plasminogen activator inhibitor type 1 in endothelial cells by constituents of platelets and their implications for thrombolysis Circulation 83 1991 645 651
12. M Levi B Biemond AJ van Zonnenweld Inhibition of plasminogen activator inhibitor-1 activity results in promotion of endogenous thrombolysis and inhibition of thrombus extension in models of experimental thrombosis Circulation 85 1992 305 312
13. RP Gray YS Yudkin DL. Patterson Enzymatic evidence of impaired reperfusion in diabetic patients after thrombolytic therapy for acute myocardial infarction: a role for plasminogen activator inhibitor? Br Heart J 70 1993 530 536
14. K Huber R Beckman F Rauscha The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator Z Kardiol 82 1993 195 200
15. DC Sane DC Stump EJ Topol Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarction Thromb Haemost 65 1991 275 279
16. LO Almer H. Ohlin Elevated levels of the rapid inhibitor of plasminogen activator (t-PAI) in acute myocardial infarction Thromb Res 47 1987 335 339
17. GI Barbash H Hod A Roth Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction Am J Cardiol 64 1989 1231 1235
18. S Dawson A. Henney The status of PAI-1 as a risk factor for arterial and thrombotic disease: a review Atherosclerosis 95 1992 105 117
19. HV Anderson JT. Willerson Thrombolysis in acute myocardial infarction N Engl J Med 329 1993 703 709
20. HD. White Selecting a thrombolytic agent Cardiol Clin 13 1995 347 354
21. Bull SSCC/SGKC. 23 1982 5 Enzymes supplement
22. A Hamsten B Wiman U de Faire Increased plasma levels of rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction N Engl J Med 313 1985 1557 1563
23. H Hamsten de Faire G Walldius Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction Lancet II 1987 3 9
24. B Kircher EJ Topol WW O’Neill Prediction of infarct coronary recanalization after intravenous thrombolytic therapy Am J Cardiol 59 1987 513 515
25. V Pasceri F Andreotti A. Masseri Clinical markers of thrombolytic success Eur Heart J 17 suppl E 1996 35 41
26. R Schroeder K Wegscheider K Schroeder Extent of early ST segment elevation resolution: a strong predictor of outcome in patients with acute myocardial infarction and a sensitive measure to compare thrombolytic regimens. A substudy of the international joint efficacy comparison of thrombolytics (INJECT) trial J Am Coll Cardiol 26 1995 1657 1664
27. B Lown TB. Graboys Sudden death: an ancient problem newly perceived Cardiovasc Med 2 1977 219 229
28. T Killip JT. Kimball Treatment of myocardial infarction in a coronary care unit. A two years experience with 250 patients Am J Cardiol 20 1967 457 464
29. Š Adamič Temelji biostatistike 1989 Zaloz×ila Medicinska fakulteta Univerze v Ljubljani Ljubljana 155 166
30. The GUSTO investigators An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction N Engl J Med 329 1993 673 682
31. P van Loon DC Rijkan EJP Bronmer The amount of plasminogen, tissue type plasminogen activator and plasminogen activator inhibitor type 1 in human thrombi and the relation to ex-vivo lysibility Thromb Haemost 67 1992 101 105